Teerha Piratvisuth
- Hepatology top 0.05%
- Hepatitis C virus research 90
- Liver Disease and Transplantation 19
- Hepatocellular Carcinoma Treatment and Prognosis 18
- Hepatitis Viruses Studies and Epidemiology 8
- Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment 95
- Hepatitis B Virus Studies 94
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 9
- Immunology top 10%
- Virology top 10%
-
- Organ Transplantation Techniques and Outcomes 6
In The Last Decade
Teerha Piratvisuth
143 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Hepatology 7.2k
- Epidemiology 7.4k
- Infectious Diseases 541
- Immunology 255
- Virology 37
Countries citing papers authored by Teerha Piratvisuth
This map shows the geographic impact of Teerha Piratvisuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teerha Piratvisuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teerha Piratvisuth more than expected).
Fields of papers citing papers by Teerha Piratvisuth
This network shows the impact of papers produced by Teerha Piratvisuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teerha Piratvisuth. The network helps show where Teerha Piratvisuth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Teerha Piratvisuth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 16 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 10 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 20 | |
| 10 | 2018 | 22 | |
| 11 | 2018 | 2 | |
| 12 | Efficacy of Propofol With Midazolam and Meperidine Versus Midazolam and Meperidine for ERCP by Endoscopists with Variable Experience | 2014 | 1 |
| 13 | 2014 | 18 | |
| 14 | 2014 | 10 | |
| 15 | 2013 | 1 | |
| 16 | No association between IL28B genotype and response to peginterferon alfa-2a (40KD) in HBe antigen-positive and HBe antigen-negative patients with chronic hepatitis B in three large randomized clinical studies | 2013 | 1 |
| 17 | 2013 | 15 | |
| 18 | 2011 | 85 | |
| 19 | PREDICTION OF RESPONSE TO PEGINTERFERON-ALFA IN HBEAG POSITIVE CHRONIC HEPATITIS B: A MODEL BASED ON 721 PATIENTS | 2008 | 0 |
| 20 | 1995 | 72 |
About Teerha Piratvisuth
Teerha Piratvisuth is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 148 papers that have together received 7.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (95 papers), Hepatitis B Virus Studies (94 papers), Hepatitis C virus research (90 papers), Liver Disease and Transplantation (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (18 papers), HIV/AIDS drug development and treatment (9 papers), Hepatitis Viruses Studies and Epidemiology (8 papers) and Organ Transplantation Techniques and Outcomes (6 papers). The work is most often cited by research in Hepatology (7.2k citations), Epidemiology (7.4k citations) and Infectious Diseases (541 citations). Teerha Piratvisuth has collaborated with scholars based in Thailand, China and Hong Kong. Frequent co-authors include George Lau, Patrick Marcellin, Edward Gane, N. Pluck, Yun‐Fan Liaw, Jia‐Horng Kao, Stephen Locarnini, Graham Cooksley, Kwang‐Hyub Han and Cihan Yurdaydın.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.